Sirio Pharma Co., Ltd.

300791

CNE100003NB0

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
39.62 ^CNY	-0.55%		-3.37%	+14.31%

Apr. 21	Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 19	Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	CI

Sirio Pharma Co., Ltd. Approves the Profit Distribution Proposal for 2021

May 06, 2022 at 03:42 pm EDT

Sirio Pharma Co., Ltd. at its Annual General Meeting of 2021 on 05 May 2022 approved the profit distribution proposal for 2021. The company announced Cash dividend (tax included) of CNY 4.00000000 per 10 shares.

Latest news about Sirio Pharma Co., Ltd.

Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 20	CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Mar. 19	CI
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.	Mar. 17	CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Jan. 02	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	23-09-24	CI
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index	23-09-18	CI
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	23-09-15	CI
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.	23-09-13	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023	23-06-01	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022	23-04-21	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index	22-12-19	CI
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition	22-12-08	MT
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.	22-10-16	CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.	22-09-24	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Sirio Pharma to Buy 80% of US Rival Best Formulations for $180 Million; Shares Slump 4%	22-07-10	MT
Sirio Pharma Plans to Raise Up to CNY 1.35 Billion in Share Private Placement	22-07-07	CI
Sirio Pharma Co., Ltd. agreed to acquire 80% stake in Ultimate Formulations, Inc.	22-07-06	CI
Sirio Pharma Co., Ltd. announced that it expects to receive CNY 1.35 billion in funding	22-07-05	CI
Sirio Pharma Co., Ltd. Announces Final Profit Distribution Plan for 2021 on A Shares, Payable on 23 May 2022	22-05-17	CI

Chart Sirio Pharma Co., Ltd.

Duration

Period

More charts

Company Profile

Sirio Pharma Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of nutritional health food. The Company's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The Company's own brand is WEWOW nutritional health food. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Food Processing

Calendar

2024-05-28 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Sirio Pharma Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

39.62 CNY

Average target price

41.67 CNY

Spread / Average Target

+5.17%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
SIRIO PHARMA CO., LTD.	+14.31%	992M
ZHEJIANG NHU COMPANY LTD.	+15.09%	8.35B
BELLRING BRANDS, INC.	+3.37%	7.62B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+1.45%	6.01B
THE SIMPLY GOOD FOODS COMPANY	-6.26%	3.75B
BYHEALTH CO., LTD	-9.86%	3.7B
XIAMEN KINGDOMWAY GROUP COMPANY	-6.55%	1.34B
HERBALIFE LTD.	-28.83%	1.13B
USANA HEALTH SCIENCES, INC.	-10.78%	925M
JAMIESON WELLNESS INC.	-17.08%	789M

Special Foods & Wellbeing Products